Home › Cancro (tutti i tipi) › North Carolina
Studi clinici su Cancro (tutti i tipi) nello stato di North Carolina
90 studi su Cancro (tutti i tipi) cercano partecipanti presso sedi nello stato di North Carolina.
Città nello stato di North Carolina
Testo ufficiale dello studio (inglese)
Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of Care
- East Carolina University, Greenville
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 5 ott 2026 · NCT07195591A Study of Mocertatug Rezetecan in Combination With Anti-cancer Therapies for Advanced Solid Tumors (BEHOLD-2)
- GSK Investigational Site, Durham
In reclutamentoFase 1/2
Età 18 e oltre · Tutti i sessi · Aggiornato il 2 ott 2026 · NCT06796907Distance-Based Exercise to Preserve Function and Prevent Disability
- Novant Health Cancer Institute - Kernersville, Kernersville
- Novant Health Cancer Institute - Mount Airy, Mount Airy
- Novant Health Forsyth Medical Center, Winston-Salem
In reclutamento
Età 18 e oltre · Tutti i sessi · Aggiornato il 2 ott 2026 · NCT07059884A Study of PHN-012 in Patients With Advanced Solid Tumors
- PHN-012-001 Site, Durham
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 29 set 2026 · NCT07127874Registry Study for Radiation Therapy Outcomes
- Atrium Health Levine Cancer Proton & Advanced Radiation Center, Charlotte
In reclutamentoStudio osservazionale
Tutte le età · Tutti i sessi · Aggiornato il 29 set 2026 · NCT01255748uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto
- The University of North Carolina Chapel Hill, Chapel Hill
In reclutamentoStudio osservazionale
Età 18 e oltre · Tutti i sessi · Aggiornato il 29 set 2026 · NCT05874921A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
- UNC Hospitals, The University of North Carolina at Chapel Hill, Chapel Hill
- Levine Cancer Institute, Charlotte
- University of North Carolina Hospitals at Hillsborough, Hillsborough
In reclutamentoFase 2/3
Età 18 e oltre · Tutti i sessi · Aggiornato il 25 set 2026 · NCT06989437A Study of JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated Myeloproliferative Neoplasms
- Levine Cancer Institute, Charlotte
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 25 set 2026 · NCT06150157A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
- Messino Cancer Centers Asheville, Asheville
- Duke University Medical Center, Durham
- FirstHealth Cancer Center, Pinehurst
In reclutamentoFase 3
Età da 18 a 100 · Tutti i sessi · Aggiornato il 25 set 2026 · NCT05920356A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
- University of North Carolina at Chapel Hill, Chapel Hill
- Duke University Medical Center - Duke Cancer Centre, Durham
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 24 set 2026 · NCT06901531Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
- Quetzal Site 27, Chapel Hill
In reclutamentoFase 3
Età da 18 a 71 · Tutti i sessi · Aggiornato il 23 set 2026 · NCT07504458A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
- FirstHealth of the Carolinas- Speciality Center /ID# 279857, Pinehurst
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 23 set 2026 · NCT07365241Study of the Effect of Innate on the Inflammatory Response to Endotoxin
- NIEHS Clinical Research Unit (CRU), Research Triangle Park
In reclutamentoStudio osservazionaleVolontari sani benvenuti
Età da 18 a 100 · Tutti i sessi · Aggiornato il 22 set 2026 · NCT01143480TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
- Lineberger Comprehensive Cancer Center, Chapel Hill
- Atrium Health's Levine Cancer Institute, Charlotte
In reclutamentoFase 2
Età 12 e oltre · Tutti i sessi · Aggiornato il 22 set 2026 · NCT02693535Prospective Study to Assess a Diagnostic Aid for Cancer
- Wilmington Health, PLLC, Wilmington
In reclutamentoStudio osservazionale
Età 45 e oltre · Tutti i sessi · Aggiornato il 21 set 2026 · NCT07046260Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
- The University of North Carolina at Chapel Hill, Chapel Hill
- Levine Cancer Institute, Charlotte
- Duke University Medical Center, Durham
- e altri 1
In reclutamentoFase 2/3
Tutte le età · Tutti i sessi · Aggiornato il 18 set 2026 · NCT03435796Digital Art Therapy for Young Cancer Survivors
- Lineberger Comprehensive Cancer Center, Chapel Hill
In reclutamento
Età da 18 a 25 · Tutti i sessi · Aggiornato il 17 set 2026 · NCT06789666Autologous CAR-T Cells Targeting CSPG4 in Relapsed/Refractory HNSCC
- Lineberger Comprehensive Cancer Center at University of North Carolina Chapel Hill, Chapel Hill
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 16 set 2026 · NCT06096038RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
- University of North Carolina at Chapel Hill, Chapel Hill
In reclutamentoFase 2
Età da 18 a 80 · Tutti i sessi · Aggiornato il 15 set 2026 · NCT07002034A Study to Assess Adverse Events and Change in Disease Activity of Oral Surzetoclax Alone or in Combination With Subcutaneous and/or Oral Antimyeloma Agents in Adult Participants With Multiple Myeloma (MM)
- University of North Carolina at Chapel Hill /ID# 272454, Chapel Hill
- Atrium Health Levine Cancer Institute /ID# 271510, Charlotte
- Wake Forest Baptist Health /ID# 271294, Winston-Salem
In reclutamentoFase 1/2
Età 18 e oltre · Tutti i sessi · Aggiornato il 14 set 2026 · NCT06953960A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies
- Research Site, Charlotte
In reclutamentoFase 1/2
Età 18 e oltre · Tutti i sessi · Aggiornato il 11 set 2026 · NCT05123482A Phase 1/1b Study of IAM1363 in HER2 Cancers
- Duke Cancer Institute, Durham
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 9 set 2026 · NCT06253871A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
- University of North Carolina Medical Center, Chapel Hill
- Duke Cancer Institute, Durham
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 8 set 2026 · NCT06119581A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer
- Oncology Specialists of Charlotte, Charlotte
- Southern Oncology Specialists, Huntersville
In reclutamentoFase 2
Età 18 e oltre · Tutti i sessi · Aggiornato il 4 set 2026 · NCT07169851Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation
- Duke Cancer Center, Durham
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 3 set 2026 · NCT06252649Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
- Regional Medical Oncology Center_Wlson, Wilson
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 2 set 2026 · NCT06072612Comprehensive Care for AYA: Needs Assessment Survey
- Atrium Health Levine Cancer, Charlotte
- Atrium Health Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem
In reclutamentoStudio osservazionale
Età 15 e oltre · Tutti i sessi · Aggiornato il 27 ago 2026 · NCT07196241A Study of ARC-02 in B-cell NHL
- Levine Cancer Institute, Charlotte
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 26 ago 2026 · NCT07691606Project: Every Child for Younger Patients With Cancer
- Mission Hospital, Asheville
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill
- Carolinas Medical Center/Levine Cancer Institute, Charlotte
- e altri 4
In reclutamentoStudio osservazionale
Fino a 25 anni · Tutti i sessi · Aggiornato il 25 ago 2026 · NCT02402244Using Tailored mHealth Strategies to Promote Weight Management Among Adolescent and Young Adult Cancer Survivors
- University of North Carolina at Chapel Hill, Chapel Hill
In reclutamento
Età da 18 a 39 · Tutti i sessi · Aggiornato il 24 ago 2026 · NCT06848491Abatacept in Immune Checkpoint Inhibitor Myocarditis
- University of North Carolina Chapel Hill, Chapel Hill
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 20 ago 2026 · NCT05335928Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
- Lineberger Comprehensive Cancer Center, Chapel Hill
In reclutamentoFase 1
Età da 18 a 99 · Tutti i sessi · Aggiornato il 19 ago 2026 · NCT03454035FOG-001 in Locally Advanced or Metastatic Solid Tumors
- Duke University, Durham
In reclutamentoFase 1/2
Età 18 e oltre · Tutti i sessi · Aggiornato il 17 ago 2026 · NCT05919264Behavioral Pain Intervention for Older Cancer Patients
- Duke Cancer Network, Durham
In reclutamento
Età 55 e oltre · Donne · Aggiornato il 12 ago 2026 · NCT07300995A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer
- Duke Cancer Institute, Durham
In reclutamentoFase 1
Età 18 e oltre · Uomini · Aggiornato il 10 ago 2026 · NCT06067841Expanding the Support of Family Caregivers of Diverse Patients With Cancer and Diabetes
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill
In reclutamentoVolontari sani benvenuti
Età da 18 a 99 · Tutti i sessi · Aggiornato il 10 ago 2026 · NCT07061652Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill
- Duke University Medical Center, Durham
- Duke Women's Cancer Care Raleigh, Raleigh
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 7 ago 2026 · NCT06580314Role of Mitochondrial Bioenergetics in Resilience for Gynecologic Cancer
- Atrium Health Levine Cancer, Charlotte
- Atrium Health Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem
In reclutamentoStudio osservazionale
Età 50 e oltre · Donne · Aggiornato il 30 lug 2026 · NCT07046936Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial Cancer
- FirstHealth of the Carolinas, Inc., Pinehurst
In reclutamentoFase 3
Età 18 e oltre · Donne · Aggiornato il 28 lug 2026 · NCT07022483A Single-arm, Phase II Clinical Trial of ASPIRin to prEvent Venous Thromboembolism in Patients With Advanced Germ Cell Tumors Receiving Chemotherapy
- Atrium Health Wake Forest Baptist Comprehensive Cancer Center, Charlotte
- Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem
In reclutamentoFase 2
Età da 18 a 70 · Tutti i sessi · Aggiornato il 24 lug 2026 · NCT06866964Fonte: ClinicalTrials.gov, dati recuperati il 6 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.